➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Johnson and Johnson
Medtronic
Mallinckrodt
Moodys

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Litigation Details for Adasa Inc. v. Avery Dennison Corporation (D. Or. 2017)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Adasa Inc. v. Avery Dennison Corporation (D. Or. 2017)

Docket   Start Trial Date Filed 2017-10-24
Court District Court, D. Oregon Date Terminated
Cause 35:271 Patent Infringement Assigned To
Jury Demand Both Referred To
Parties ADASA INC.; AVERY DENNISON CORPORATION
Patents 10,071,977; 10,130,598; 10,155,801; 10,201,672; 10,525,114; 10,525,120; 10,525,124; 6,437,165; 6,525,242; 6,713,662; 7,143,812; 7,285,668; 7,544,713; 7,556,798; 7,598,271; 7,662,143; 7,713,570; 7,807,689; 7,807,708; 7,867,114; 8,071,525; 8,112,609; 8,114,598; 8,133,970; 8,133,977; 8,609,112; 8,708,437; 8,841,287; 9,114,451; 9,155,699; 9,556,260; 9,801,977
Attorneys Alan J. Thayer , Jr.; Angela E. Addae; Balazs Takacs; Brenna K. Legaard; Brett M. Pinkus; Cristin A. Wagner; Glenn S. Orman; Johnathan E. Mansfield; Jonathan T. Suder; Richard A. Wojcio , Jr.; William F. Abrams
Firms Friedman, Suder & Cooke; Harris Bricken McVay, LLP; Schwabe Williamson and Wyatt PC; Schwabe, Williamson & Wyatt; Schwabe, Williamson & Wyatt, P.C.
Link to Docket External link to docket
Small Molecule Drugs cited in Adasa Inc. v. Avery Dennison Corporation
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Adasa Inc. v. Avery Dennison Corporation (D. Or. 2017)

Date Filed Document No. Description Snippet Link To Document
2020-04-30 165 Opinion and Order ORDER Case 6:17-cv-01685-MK Document 165 Filed 04/30/20 Page 6 of 10 …abstracted from 6 – OPINION AND ORDER Case 6:17-cv-01685-MK Document 165 Filed 04…Def.’s Mot. J. 6-7, ECF No. 115 (citing Microsoft Corp. v. AT&T Corp., 550 U.S. 437 (2006)); Def.’… PACER Document Case 6:17-cv-01685-MK Document 165 Filed 04/30/20 Page …– OPINION AND ORDER Case 6:17-cv-01685-MK Document 165 Filed 04/30/20 Page 2 External link to document
2020-04-30 166 Opinion and Order ‘967 Patent are patentable. Am. Compl. Ex. A, 42, Ex Parte Reexamination Certificate, ECF No. 71-1. Plaintiff…claims from the ‘967 Patent as issued in the Reexamination Certificate. ECF No. 71. Defendant filed an …Kaufman Co., Inc. v. Lantech, Inc., 807 F.2d 970, 977 (Fed. Cir. 1984) (emphasis added). The question …that Defendant infringed its U.S. Patent No. 9,798,967 (“ ‘967 Patent”). ECF No. 1. Defendant filed an…, 42, Ex Parte Reexamination Certificate, ECF No. 71-1 (emphasis in original); see also Am. Resp. Final External link to document
2020-04-30 167 Opinion and Order the serial number field.” The ‘198 Patent, 18:34-38, ECF No. 130-14. Defendant claims that “[t]his revision…McAllister Decl. ¶¶ 6-7, ECF No. 130-8; Engels Decl. ¶ 62, ECF No. 130-4. Specifically, the “Ad Hoc Mode…” Engels Decl. ¶ 63, ECF No. 130-4; McAllister Decl. ¶¶ 6-7, ECF No. 130-8. Defendant does not refute…Decl. ¶¶ 43-44, ECF No. 130-4 (citing 2008 Application [0015], [0049], ECF No. 130-3) (emphasis supplied… ¶ 52, ECF No. 130-4 (citing the 2008 Application, [0049], [0051], [0015] ECF No. 130-3) (emphasis supplied External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Boehringer Ingelheim
Medtronic
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.